Inhibitors of ApiAP2 protein DNA binding exhibit multistage activity against Plasmodium parasites

<jats:p><jats:italic>Plasmodium</jats:italic> parasites are reliant on the Apicomplexan AP2 (ApiAP2) transcription factor family to regulate gene expression programs. AP2 DNA binding domains have no homologs in the human or mosquito host genomes, making them potential antimalarial...

Full description

Bibliographic Details
Main Authors: Russell, Timothy James, De Silva, Erandi K, Crowley, Valerie M, Shaw-Saliba, Kathryn, Dube, Namita, Josling, Gabrielle, Pasaje, Charisse Flerida A, Kouskoumvekaki, Irene, Panagiotou, Gianni, Niles, Jacquin C, Jacobs-Lorena, Marcelo, Denise Okafor, C, Gamo, Francisco-Javier, Llinás, Manuel
Other Authors: Massachusetts Institute of Technology. Department of Biological Engineering
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2023
Online Access:https://hdl.handle.net/1721.1/147888
_version_ 1811073734256099328
author Russell, Timothy James
De Silva, Erandi K
Crowley, Valerie M
Shaw-Saliba, Kathryn
Dube, Namita
Josling, Gabrielle
Pasaje, Charisse Flerida A
Kouskoumvekaki, Irene
Panagiotou, Gianni
Niles, Jacquin C
Jacobs-Lorena, Marcelo
Denise Okafor, C
Gamo, Francisco-Javier
Llinás, Manuel
author2 Massachusetts Institute of Technology. Department of Biological Engineering
author_facet Massachusetts Institute of Technology. Department of Biological Engineering
Russell, Timothy James
De Silva, Erandi K
Crowley, Valerie M
Shaw-Saliba, Kathryn
Dube, Namita
Josling, Gabrielle
Pasaje, Charisse Flerida A
Kouskoumvekaki, Irene
Panagiotou, Gianni
Niles, Jacquin C
Jacobs-Lorena, Marcelo
Denise Okafor, C
Gamo, Francisco-Javier
Llinás, Manuel
author_sort Russell, Timothy James
collection MIT
description <jats:p><jats:italic>Plasmodium</jats:italic> parasites are reliant on the Apicomplexan AP2 (ApiAP2) transcription factor family to regulate gene expression programs. AP2 DNA binding domains have no homologs in the human or mosquito host genomes, making them potential antimalarial drug targets. Using an <jats:italic>in-silico</jats:italic> screen to dock thousands of small molecules into the crystal structure of the AP2-EXP (Pf3D7_1466400) AP2 domain (PDB:3IGM), we identified putative AP2-EXP interacting compounds. Four compounds were found to block DNA binding by AP2-EXP and at least one additional ApiAP2 protein. Our top ApiAP2 competitor compound perturbs the transcriptome of <jats:italic>P</jats:italic>. <jats:italic>falciparum</jats:italic> trophozoites and results in a decrease in abundance of log<jats:sub>2</jats:sub> fold change &gt; 2 for 50% (46/93) of AP2-EXP target genes. Additionally, two ApiAP2 competitor compounds have multi-stage anti-<jats:italic>Plasmodium</jats:italic> activity against blood and mosquito stage parasites. In summary, we describe a novel set of antimalarial compounds that interact with AP2 DNA binding domains. These compounds may be used for future chemical genetic interrogation of ApiAP2 proteins or serve as starting points for a new class of antimalarial therapeutics.</jats:p>
first_indexed 2024-09-23T09:37:47Z
format Article
id mit-1721.1/147888
institution Massachusetts Institute of Technology
language English
last_indexed 2024-09-23T09:37:47Z
publishDate 2023
publisher Public Library of Science (PLoS)
record_format dspace
spelling mit-1721.1/1478882023-02-07T03:44:43Z Inhibitors of ApiAP2 protein DNA binding exhibit multistage activity against Plasmodium parasites Russell, Timothy James De Silva, Erandi K Crowley, Valerie M Shaw-Saliba, Kathryn Dube, Namita Josling, Gabrielle Pasaje, Charisse Flerida A Kouskoumvekaki, Irene Panagiotou, Gianni Niles, Jacquin C Jacobs-Lorena, Marcelo Denise Okafor, C Gamo, Francisco-Javier Llinás, Manuel Massachusetts Institute of Technology. Department of Biological Engineering <jats:p><jats:italic>Plasmodium</jats:italic> parasites are reliant on the Apicomplexan AP2 (ApiAP2) transcription factor family to regulate gene expression programs. AP2 DNA binding domains have no homologs in the human or mosquito host genomes, making them potential antimalarial drug targets. Using an <jats:italic>in-silico</jats:italic> screen to dock thousands of small molecules into the crystal structure of the AP2-EXP (Pf3D7_1466400) AP2 domain (PDB:3IGM), we identified putative AP2-EXP interacting compounds. Four compounds were found to block DNA binding by AP2-EXP and at least one additional ApiAP2 protein. Our top ApiAP2 competitor compound perturbs the transcriptome of <jats:italic>P</jats:italic>. <jats:italic>falciparum</jats:italic> trophozoites and results in a decrease in abundance of log<jats:sub>2</jats:sub> fold change &gt; 2 for 50% (46/93) of AP2-EXP target genes. Additionally, two ApiAP2 competitor compounds have multi-stage anti-<jats:italic>Plasmodium</jats:italic> activity against blood and mosquito stage parasites. In summary, we describe a novel set of antimalarial compounds that interact with AP2 DNA binding domains. These compounds may be used for future chemical genetic interrogation of ApiAP2 proteins or serve as starting points for a new class of antimalarial therapeutics.</jats:p> 2023-02-06T15:05:54Z 2023-02-06T15:05:54Z 2022 2023-02-06T14:51:11Z Article http://purl.org/eprint/type/JournalArticle https://hdl.handle.net/1721.1/147888 Russell, Timothy James, De Silva, Erandi K, Crowley, Valerie M, Shaw-Saliba, Kathryn, Dube, Namita et al. 2022. "Inhibitors of ApiAP2 protein DNA binding exhibit multistage activity against Plasmodium parasites." PLoS Pathogens, 18 (10). en 10.1371/JOURNAL.PPAT.1010887 PLoS Pathogens Creative Commons Attribution 4.0 International license https://creativecommons.org/licenses/by/4.0/ application/pdf Public Library of Science (PLoS) PLoS
spellingShingle Russell, Timothy James
De Silva, Erandi K
Crowley, Valerie M
Shaw-Saliba, Kathryn
Dube, Namita
Josling, Gabrielle
Pasaje, Charisse Flerida A
Kouskoumvekaki, Irene
Panagiotou, Gianni
Niles, Jacquin C
Jacobs-Lorena, Marcelo
Denise Okafor, C
Gamo, Francisco-Javier
Llinás, Manuel
Inhibitors of ApiAP2 protein DNA binding exhibit multistage activity against Plasmodium parasites
title Inhibitors of ApiAP2 protein DNA binding exhibit multistage activity against Plasmodium parasites
title_full Inhibitors of ApiAP2 protein DNA binding exhibit multistage activity against Plasmodium parasites
title_fullStr Inhibitors of ApiAP2 protein DNA binding exhibit multistage activity against Plasmodium parasites
title_full_unstemmed Inhibitors of ApiAP2 protein DNA binding exhibit multistage activity against Plasmodium parasites
title_short Inhibitors of ApiAP2 protein DNA binding exhibit multistage activity against Plasmodium parasites
title_sort inhibitors of apiap2 protein dna binding exhibit multistage activity against plasmodium parasites
url https://hdl.handle.net/1721.1/147888
work_keys_str_mv AT russelltimothyjames inhibitorsofapiap2proteindnabindingexhibitmultistageactivityagainstplasmodiumparasites
AT desilvaerandik inhibitorsofapiap2proteindnabindingexhibitmultistageactivityagainstplasmodiumparasites
AT crowleyvaleriem inhibitorsofapiap2proteindnabindingexhibitmultistageactivityagainstplasmodiumparasites
AT shawsalibakathryn inhibitorsofapiap2proteindnabindingexhibitmultistageactivityagainstplasmodiumparasites
AT dubenamita inhibitorsofapiap2proteindnabindingexhibitmultistageactivityagainstplasmodiumparasites
AT joslinggabrielle inhibitorsofapiap2proteindnabindingexhibitmultistageactivityagainstplasmodiumparasites
AT pasajecharissefleridaa inhibitorsofapiap2proteindnabindingexhibitmultistageactivityagainstplasmodiumparasites
AT kouskoumvekakiirene inhibitorsofapiap2proteindnabindingexhibitmultistageactivityagainstplasmodiumparasites
AT panagiotougianni inhibitorsofapiap2proteindnabindingexhibitmultistageactivityagainstplasmodiumparasites
AT nilesjacquinc inhibitorsofapiap2proteindnabindingexhibitmultistageactivityagainstplasmodiumparasites
AT jacobslorenamarcelo inhibitorsofapiap2proteindnabindingexhibitmultistageactivityagainstplasmodiumparasites
AT deniseokaforc inhibitorsofapiap2proteindnabindingexhibitmultistageactivityagainstplasmodiumparasites
AT gamofranciscojavier inhibitorsofapiap2proteindnabindingexhibitmultistageactivityagainstplasmodiumparasites
AT llinasmanuel inhibitorsofapiap2proteindnabindingexhibitmultistageactivityagainstplasmodiumparasites